Brilict 50 mg (Brivaracetam)

Adult dose

This product is taken twice daily. The recommended initial dose is 25mg or 50mg per dose, based on the healthcare professional's assessment of potential adverse effects relative to seizure reduction. Based on clinical response and tolerability, the dose may be increased or decreased from 50mg daily [25mg twice daily] to 200mg daily [100mg twice daily]. Take this product as a whole film-coated tablet with water. It may be taken with or without food. If you miss a dose If you miss one or more doses, take one dose as soon as you remember, then take the next dose at the next scheduled morning or evening time. Discontinuation If you wish to discontinue this product, gradually reduce the dose by 50mg daily at 1-week intervals. After taking 50mg daily for 1 week, a dose of 20mg daily is recommended during the final week (see section '1. Warnings'). Older adults (65 years or older) No dosage adjustment is necessary for older adults. Clinical experience in older patients aged 65 years or older is limited. Renal impairment No dosage adjustment is necessary for patients with renal impairment. This product is not recommended for patients with end-stage renal disease undergoing hemodialysis. Hepatic impairment Exposure to this product is increased in patients with hepatic impairment. An initial dose of 50mg daily [25mg twice daily] is recommended for patients with hepatic impairment, and a maximum dose of 150mg daily [75mg twice daily] is recommended.

This medication may increase the risk of suicidal thoughts or behaviors, so mood changes and unusual behaviors should be carefully monitored during treatment. Central nervous system-related side effects such as drowsiness, fatigue, and dizziness may occur frequently, especially during the initial phase of treatment. Abruptly discontinuing this medication can lead to increased frequency of seizures; therefore, the dosage should be reduced slowly according to the doctor's instructions. Patients who are allergic to the active substance or any of the components of this medication should not take it, and patients with certain genetic issues like lactose intolerance should also avoid using it. Patients with poor liver function may require dosage adjustments, so consultation with a physician is necessary. Severe skin reactions can occur rarely, so if symptoms such as skin rash, redness, or blistering occur, medical attention should be sought immediately. There may be interactions with other medications, so caution is advised when taken with antiepileptic drugs, certain antibiotics, antifungals, and alcohol. Women who are pregnant or nursing should consult a physician before taking this medication, and should carefully consider whether to continue use if planning to become pregnant. This medication is not recommended for children under 16 years of age as its safety and efficacy have not been sufficiently confirmed in this age group. Drowsiness or dizziness may occur with this medication, so it is advisable to avoid driving or operating machinery until these symptoms fully resolve. In case of overdose, there is no specific antidote, so if symptoms occur, it's important to seek appropriate medical treatment immediately. Finally, this medication should be stored out of reach of children, and care should be taken to keep it in its original packaging to maintain quality.

• suicidal thoughts
• suicidal behavior
• drowsiness
• fatigue
• dizziness
• coordination impairment
• influenza
• type 1 hypersensitivity reaction
• neutropenia
• decreased appetite

This medication should be stored in a tightly closed container to prevent exposure to air and moisture. It is important to maintain room temperature between 1 degree and 30 degrees Celsius.

Appearance

Yellow oval film-coated tablet

Package unit

60 tablets/PTP [10 tablets/PTP x 6]